Zoë R Wallace

  • Citations Per Year
Learn More
Zidovudine (ZDV) is a widely used component of antiretroviral therapy (ART) in resource-limited settings, despite its known adverse effects, which include mitochondrial toxicity in muscle, liver and adipose tissue. It has also been associated with impaired immunological recovery. We hypothesised that ZDV might impair mitochondrial health and survival of(More)
Persistence of human immunodeficiency virus (HIV) in a latent state in long-lived CD4+ T-cells is a major barrier to eradication. Latency-reversing agents that induce direct or immune-mediated cell death upon reactivation of HIV are a possible solution. However, clearance of reactivated cells may require immunotherapeutic agents that are fine-tuned to(More)
K. R. LeChien, M. E. Savage, V. Anaya, D. E. Bliss, W. T. Clark, J. P. Corley, G. Feltz, J. E. Garrity, D. W. Guthrie, K. C. Hodge, J. E. Maenchen, R. Maier, K. R. Prestwich, K. W. Struve, W. A. Stygar, T. Thompson, J. Van Den Avyle, P. E. Wakeland, Z. R. Wallace, and J. R. Woodworth Sandia National Laboratories, Albuquerque, New Mexico 87185, USA Ktech(More)
  • 1